EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
The approval is supported by outcomes from the multicentre, open-label Phase II TRANSCEND FL trial.
Approvals
FDA grants ODD status to Zai Lab’s lung cancer treatment
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
Yunovia receives South Korea MFDS approval for Phase I trial of GLP-1 agonist
EC conditionally approves Pfizer’s haemophilia B gene therapy
InnoCare receives clearance for leukaemia/lymphoma trial in China
FDA grants IND clearance for OKYO Pharma’s NCP treatment trial
Neurotech to begin Phase I/II trial of NTI164 for cerebral palsy
